Medical Devices
Neurovascular Embolization Devices Market

Neurovascular Embolization Devices Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Neurovascular Embolization Devices Market by Product (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, and Aneurysm Clips), End-user (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers), and Regional Analysis from 2026 to 2033

ID: PMRREP25969

December 2025

199 Pages

Author : Abhijeet Surwase

Healthcare

Preview Segmentation

Key Industry Highlights:

Leading Region: North America holds a 42.8% share of the global neurovascular embolization devices market, supported by high aneurysm detection rates, strong neuro-interventional capabilities, widespread adoption of coils and flow diverters, and favorable reimbursement structures.
Fastest-Growing Region: Asia Pacific is the fastest-growing region, driven by increasing stroke burden, rapid expansion of neurology centers, improved access to advanced imaging, and growing adoption of minimally invasive embolization technologies.
Leading Product Segment: Embolic coils dominate the product landscape due to widespread clinical acceptance, proven safety, precision in aneurysm occlusion, and broad applicability across simple and complex aneurysms.
Fastest-Growing Product Segment: Flow diversion devices are the fastest-growing segment, driven by expanding use in wide-neck and complex aneurysms, improved device designs, and rising physician preference for durable vessel reconstruction.
Leading End-user Segment: Hospitals dominate end-user adoption due to higher patient inflow, availability of hybrid cath labs, advanced neurosurgical teams, and higher procedural volumes for aneurysms and AVMs.
Fastest-Growing End-user Segment: Ambulatory surgery centers (ASCs) are growing rapidly as minimally invasive embolization procedures become shorter and safer, and are increasingly performed in outpatient settings.

Key Insights	Details
Neurovascular Embolization Devices Market Size (2026E)	US$ 1.8 Bn
Market Value Forecast (2033F)	US$ 3.0 Bn
Projected Growth (CAGR 2026 to 2033)	6.9%
Historical Market Growth (CAGR 2020 to 2025)	5.3%

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Rising Burden of Neurovascular Disorders and Growing Shift Toward Minimally Invasive Interventions

The increasing global burden of intracranial aneurysms and arteriovenous malformations (AVMs), coupled with higher detection rates from routine magnetic resonance imaging (MRI) and computed tomography angiography (CTA), is driving the neurovascular embolization devices market.

As screening programs expand and populations age, hospitals across North America, Europe, and Asia are witnessing a steady rise in neuro-interventional case volumes, pushing demand for advanced embolization devices.

For instance, in October 2023, the World Federation of Neurology reported that neurological disorders have become the second-leading cause of death and the foremost cause of disability globally. Findings from the latest global burden of disease (GBD) study further indicate that the number of people affected by brain-related conditions is projected to double by 2050.

Moreover, a strong transition from open neurosurgery to minimally invasive, catheter-based neuro-interventional techniques. Coils, flow diverters, and liquid embolic agents are now preferred due to shorter recovery times, reduced procedural risk, and improved patient outcomes. This shift is prompting hospitals and ambulatory centers to scale up neuro-interventional infrastructure, further driving the adoption of embolization devices.

Restraints - High Treatment Costs and Ongoing Procedural Risks Limiting Broader Adoption

The high cost of neurovascular embolization procedures, particularly those involving flow diverters, coils, and liquid embolics, continues to place a substantial financial strain on healthcare systems. Hospitals in low-income and underfunded regions face even greater challenges, as limited reimbursement policies across parts of APAC, LATAM, and Africa restrict wider access and slow the adoption of advanced embolization technologies.

Additionally, the procedural risks and device-related complications remain key restraints in the market. Despite technological advances, issues such as re-canalization, thromboembolic events, coil migration, and incomplete occlusion persist, affecting clinical outcomes.

These risks reduce physician confidence and contribute to stricter regulatory scrutiny, delaying approvals and impacting market growth, as a result of improved medical expulsive therapies that reduce the need for device-based intervention.

Opportunity - Technological Advancements and Expanding Clinical Applications

Rapid innovation in neurovascular embolization devices, ranging from detachable and soft coils to high-porosity braided flow diverters, dual-lumen catheters, and next-generation liquid embolics, has significantly improved procedural outcomes.

These advancements enable effective treatment of complex, wide-neck aneurysms and have accelerated the adoption of low-profile, dual-layer flow-diversion systems across tertiary hospitals. As demand rises for devices capable of managing challenging anatomies, manufacturers see strong growth potential in the continued evolution of flow-modulation technologies.

Furthermore, the clinical utility of liquid embolic agents is expanding beyond aneurysm repair into AVMs, fistulas, hypervascular tumors, and pre-operative embolization, creating multiple revenue pathways.

Growing interest in bioactive coils, shape-memory polymers, radiopaque materials, and bioresorbable embolic platforms, supported by an increasing number of clinical trials, is attracting substantial investment. Companies advancing novel materials or integrating AI-based navigation and imaging guidance stand to gain early-market advantages as the treatment ecosystem continues to diversify.

Category-wise Analysis

By Product Insights

The embolic coils segment is projected to dominate the global neurovascular embolization devices market in 2026, accounting for a revenue share of 56.4%. Clinical and technological factors primarily drive the segment’s strong performance.

Coils remain the first-line treatment for a wide range of intracranial aneurysms due to their long-established safety profile, versatility, and extensive physician familiarity. Continuous improvements, such as softer, stretch-resistant, and detachable coil designs, have enhanced precision, packing density, and procedural outcomes, which further strengthen adoption across high-volume neuro-interventional centers.

Their compatibility with a broad range of microcatheters and adjunctive devices such as stents, balloons, and flow diverters adds to their clinical flexibility. In addition, rising global screening rates for unruptured aneurysms, expansion of neuro-interventional infrastructure, and increasing availability of trained specialists support higher procedure volumes.

By End-user Insights

The hospitals segment is projected to dominate the global neurovascular embolization devices market in 2026, accounting for a revenue share 52.8%. Several structural and clinical advantages drive this. Hospitals serve as the primary centers for neuro-interventional procedures, supported by advanced imaging infrastructure, hybrid cath labs, and dedicated neuro-ICUs required for complex aneurysm and AVM treatments.

They also have a higher concentration of skilled neuro-interventional radiologists and neurosurgeons, enabling consistent handling of high-risk and emergency cases.

Growing investments in hospital-based stroke and neurovascular programs, along with increasing adoption of minimally invasive interventions, continue to boost procedure volumes. Additionally, hospitals manage a larger share of acute admissions, such as ruptured aneurysms and AVMs, making them the preferred setting for advanced embolization therapies.

Expanding reimbursement coverage for inpatient neurovascular procedures further reinforces the segment’s dominant position.

Request Free sampleRequest Free sample

Region-wise Insights

North America Neurovascular Embolization Devices Market Trends

North America is expected to dominate globally with a share of 42.8% in 2026, as the U.S. is the leading market due to a well-established healthcare infrastructure, widespread access to advanced neuro-interventional technologies, and a high concentration of specialized neurosurgeons and neuro-interventional radiologists.

The region also benefits from robust clinical adoption of flow diverters, detachable coils, and next-generation liquid embolics, supported by early regulatory approvals and rapid integration of new devices into hospital systems.

The rising prevalence of intracranial aneurysms, AVMs, ischemic stroke, and other cerebrovascular conditions-further amplified by aging demographics-continues to increase the number of minimally invasive neurovascular procedures performed each year. Additionally, the presence of leading manufacturers, strong R&D activities, and frequent product launches fuel market competitiveness.

Favorable reimbursement policies for endovascular aneurysm repair in the U.S. further drive utilization across high-volume centers. Growing investments in stroke centers, along with expanding adoption of image-guided interventions, drive North America’s region market growth.

Europe Neurovascular Embolization Devices Market Trends

Europe is expected to achieve steady growth driven by the rising demand for high-precision dental restorations, expanding dental implant procedures, and the rapid shift toward digital dentistry across clinics and laboratories.

Countries such as Germany, the U.K., France, Italy, and the Nordic region are experiencing strong adoption of computer-aided design (CAD) and computer-aided manufacturing (CAM) workflows, which directly increases demand for advanced sintering, muffle, and vacuum ovens capable of producing consistent, high-strength zirconia prostheses.

Growing awareness of aesthetic dental treatments, coupled with an aging population experiencing higher rates of edentulism and restorative dental needs, is further accelerating equipment upgrades in both public and private dental facilities.

Additionally, Europe benefits from a well-established network of dental laboratories, robust reimbursement for certain restorative procedures, and ongoing investments in dental education and training programs.

The presence of key oven manufacturers, increasing import volumes of high-temperature sintering units, and the expansion of centralized milling centers contribute to steady market penetration. Environmental regulations promoting energy-efficient equipment and the push toward automation and quality standardization are encouraging laboratories to replace older systems with digitally integrated, temperature-stable, and rapid-cycle ovens.

Asia Pacific Neurovascular Embolization Devices Market Trends

The Asia Pacific market is expected to register a relatively higher CAGR of around 9.3% between 2026 and 2033, driven by stronger healthcare investments, rapid infrastructure upgrades, and the region’s growing focus on minimally invasive neurovascular interventions.

Countries such as China, Japan, India, and South Korea are expanding their neurosurgical capabilities through new stroke centers, greater availability of hybrid operating rooms, and national initiatives to improve acute stroke care pathways.

The rising incidence of intracranial aneurysms and ischemic stroke, amplified by aging populations, sedentary lifestyles, and increasing hypertension prevalence, is also pushing hospitals to adopt advanced embolization devices like coils, liquid embolics, and flow diverters.

Moreover, medical tourism hubs, including India, Thailand, and Malaysia, are further driving demand by offering cost-effective neurointerventional procedures that draw patients from the Middle East, Africa, and Southeast Asia. The expanding reimbursement frameworks in Australia, Japan, and South Korea are making endovascular treatments more accessible.

Competitive Landscape

The global neurovascular embolization devices market is highly competitive, with major players such as Medtronic, Stryker Corporation, Terumo Neuro, Johnson & Johnson, and Penumand Inc. These companies capitalize on broad product lines, strong expertise in endovascular technologies, and extensive global distribution networks to maintain leadership.

Industry players are increasingly focusing on developing advanced embolization solutions, including high-precision coils, liquid embolics, intrasaccular devices, and next-generation flow diverters engineered to improve navigability, enhance occlusion efficiency, and support complex aneurysm and AVM interventions.

Manufacturers are accelerating R&D efforts around microcatheter innovation, enhanced visibility materials, and device systems integrated with real-time imaging guidance to boost procedural accuracy and safety.

Competitive strategies also include strategic acquisitions to expand neurovascular portfolios, collaborations with leading stroke and neurosurgical centers for clinical evidence generation, and targeted expansion into high-growth markets such as Asia Pacific, Latin America, and the Middle East.

Key Industry Developments:

In March 2024, CERENOVUS Inc. announced the launch of its TRUFILL™ n-BCA Liquid Embolic System Procedural Set, expanding the company’s hemorrhagic stroke treatment portfolio. The new offering provides TRUFILL™ n-BCA as a comprehensive procedural set featuring two configuration options along with all necessary accessories for preparation and delivery.
In September 2023, Rapid Medical™ announced new clinical evidence demonstrating the superior performance of its COMANECI™ embolization assist device for treating ruptured wide-neck intracranial aneurysms. According to a meta-analysis published in World Neurosurgery, COMANECI showed notably lower rates of hemorrhagic and thromboembolic complications and higher complete occlusion rates compared with traditional stent-assisted and balloon-assisted coiling methods.

Companies Covered in Neurovascular Embolization Devices Market

Medtronic
Stryker Corporation
Terumo Neuro
Johnson & Johnson
Penumbra Inc.
Balt
B. Braun SE
Integra LifeSciences Corporation
Resonetics
Acandis GmbH
Abbott
phenox GmbH
Others

Frequently Asked Questions

The global neurovascular embolization devices market is projected to be valued at US$ 1.8 Bn in 2026.

Rising burden of intracranial aneurysms and AVMs, growing adoption of minimally invasive neuro-interventions, and continuous advancements in coils, flow diverters, and liquid embolics are driving the global neurovascular embolization devices market.

The global neurovascular embolization devices market is poised to witness a CAGR of 6.9% between 2026 and 2033.

Rapid adoption of next-generation flow diverters, and growing innovation in bioactive, polymer-based, and AI-enabled embolization technologies are creating opportunities in the market.

Medtronic, Stryker Corporation, Terumo Neuro, Johnson & Johnson, and Penumand Inc are some key players in the neurovascular embolization devices market.

Report Attribute	Details
Historical Data/Actuals	2020 - 2025
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Bn Volume (Units) If Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Product By End-user By Region
Competitive Analysis	Medtronic Stryker Corporation Terumo Neuro Johnson & Johnson Penumbra Inc. Balt B. Braun SE Integra LifeSciences Corporation Resonetics Acandis GmbH Abbott phenox GmbH Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Neurovascular Embolization Devices Market Size (2026E)

US$ 1.8 Bn

Market Value Forecast (2033F)

US$ 3.0 Bn

Projected Growth (CAGR 2026 to 2033)

6.9%

Historical Market Growth (CAGR 2020 to 2025)

5.3%

Report Attribute	Details
Historical Data/Actuals	2020 - 2025
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Bn Volume (Units) If Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Product By End-user By Region
Competitive Analysis	Medtronic Stryker Corporation Terumo Neuro Johnson & Johnson Penumbra Inc. Balt B. Braun SE Integra LifeSciences Corporation Resonetics Acandis GmbH Abbott phenox GmbH Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Executive Summary
1. Global Neurovascular Embolization Devices Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Recent Product Launches
3. Regulatory Landscape
4. Value Chain Analysis
5. Key Deals and Mergers
6. PESTLE Analysis
7. Porter’s Five Force Analysis
Price Trend Analysis, 2020 - 2033
1. Key Highlights
2. Key Factors Impacting Product Prices
3. Pricing Analysis, By Product Type
4. Regional Prices and Product Preferences
Global Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
3. Global Neurovascular Embolization Devices Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis and Volume (Units) Analysis, By Product, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
    1. Embolic Coils
    2. Flow Diversion Devices
    3. Liquid Embolic Agents
    4. Aneurysm Clips
  4. Market Attractiveness Analysis: By Product
4. Global Neurovascular Embolization Devices Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgery Centers
  4. Market Attractiveness Analysis: End User
Global Neurovascular Embolization Devices Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. Embolic Coils
  2. Flow Diversion Devices
  3. Liquid Embolic Agents
  4. Aneurysm Clips
5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgery Centers
6. Market Attractiveness Analysis
Europe Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. Embolic Coils
  2. Flow Diversion Devices
  3. Liquid Embolic Agents
  4. Aneurysm Clips
5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgery Centers
6. Market Attractiveness Analysis
East Asia Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. Embolic Coils
  2. Flow Diversion Devices
  3. Liquid Embolic Agents
  4. Aneurysm Clips
5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgery Centers
6. Market Attractiveness Analysis
South Asia & Oceania Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. Embolic Coils
  2. Flow Diversion Devices
  3. Liquid Embolic Agents
  4. Aneurysm Clips
5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgery Centers
6. Market Attractiveness Analysis
Latin America Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. Embolic Coils
  2. Flow Diversion Devices
  3. Liquid Embolic Agents
  4. Aneurysm Clips
5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgery Centers
6. Market Attractiveness Analysis
Middle East & Africa Neurovascular Embolization Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. Embolic Coils
  2. Flow Diversion Devices
  3. Liquid Embolic Agents
  4. Aneurysm Clips
5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgery Centers
6. Market Attractiveness Analysis
Competition Landscape
1. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
2. Company Profiles (Details - Overview, Recent Developments)
  1. Medtronic
    1. Overview
    2. Segments and Product & End User
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Stryker Corporation
  3. Terumo Neuro
  4. Johnson & Johnson
  5. Penumbra Inc.
  6. Balt
  7. B. Braun SE
  8. Integra LifeSciences Corporation
  9. Resonetics
  10. Acandis GmbH
  11. Abbott
  12. phenox GmbH
  13. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Neurovascular Embolization Devices Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Neurovascular Embolization Devices Market by Product (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, and Aneurysm Clips), End-user (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers), and Regional Analysis from 2026 to 2033